|
US6867179B1
(en)
|
1994-08-31 |
2005-03-15 |
Trustees Of Boston University |
Methods of inducing hair growth and coloration
|
|
US7196055B2
(en)
*
|
1994-08-31 |
2007-03-27 |
Trustees Of Boston University |
Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor
|
|
DE69736976T2
(de)
|
1996-03-29 |
2007-10-18 |
Trustees Of Boston University, Boston |
Mit Alzheimer Krankheit verknüpften Verfahren zur Diagnose, zur Herstellung von Medikamenten und zum Screenen von Substanzen sowie aus Beta-Amyloid abgeleiteten Peptiden
|
|
US6258932B1
(en)
*
|
1999-08-09 |
2001-07-10 |
Tripep Ab |
Peptides that block viral infectivity and methods of use thereof
|
|
CN1377276A
(zh)
*
|
1999-08-09 |
2002-10-30 |
特里帕普股份公司 |
含有三肽的药用组合物
|
|
KR20020007432A
(ko)
*
|
2000-07-13 |
2002-01-29 |
박현석 |
멜라노트랜스페린에 대한 단클론 항체를 유효성분으로포함하는 알츠하이머병의 진단시약
|
|
US6593455B2
(en)
*
|
2001-08-24 |
2003-07-15 |
Tripep Ab |
Tripeptide amides that block viral infectivity and methods of use thereof
|
|
US6455670B1
(en)
*
|
2001-09-06 |
2002-09-24 |
Tripep Ab |
Pentamer peptide amide, ALGPG-NH2, that inhibits viral infectivity and methods of use thereof
|
|
EP1436317A1
(en)
*
|
2001-09-19 |
2004-07-14 |
Tripep Ab |
Molecules that block viral infectivity and methods of use thereof
|
|
AUPS230702A0
(en)
*
|
2002-05-14 |
2002-06-13 |
Walter And Eliza Hall Institute Of Medical Research, The |
A method of treatment
|
|
PL378163A1
(pl)
*
|
2003-02-21 |
2006-03-06 |
Tripep Ab |
Pochodna glicynoamidu do hamowania replikacji HIV
|
|
US20050096319A1
(en)
*
|
2003-02-21 |
2005-05-05 |
Balzarini Jan M.R. |
Identification of compounds that inhibit replication of human immunodeficiency virus
|
|
JP2007528202A
(ja)
*
|
2003-03-28 |
2007-10-11 |
株式会社インテレクチャル・プロパティ・コンサルティング |
神経再生のための組成物および方法
|
|
JP4769709B2
(ja)
*
|
2003-05-08 |
2011-09-07 |
ディーエスエム アイピー アセッツ ビー．ブイ． |
皮膚の構造を改善するために美容上適用するためのトリペプチドおよびその誘導体
|
|
US7608586B2
(en)
*
|
2003-06-11 |
2009-10-27 |
The University Of Rochester |
Soluble low-density lipoprotein receptor related protein binds directly to Alzheimer's amyloid-beta peptide
|
|
EP1500399A1
(en)
*
|
2003-07-24 |
2005-01-26 |
Institut Pasteur |
Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative deseases
|
|
WO2006113097A2
(en)
*
|
2005-04-15 |
2006-10-26 |
The University Of North Carolina At Chapel Hill |
Methods of facilitating cell survival using neurotrophin mimetics
|
|
US20110230479A1
(en)
*
|
2005-04-15 |
2011-09-22 |
Longo Frank M |
Neurotrophin mimetics and uses thereof
|
|
WO2006116400A2
(en)
*
|
2005-04-27 |
2006-11-02 |
Massachusetts Institute Of Technology |
Promoter engineering and genetic control
|
|
CN101605554A
(zh)
*
|
2006-10-23 |
2009-12-16 |
国立大学法人名古屋大学 |
脑内氧化抑制剂及其应用
|
|
EP2376120A2
(en)
|
2008-11-25 |
2011-10-19 |
Biogen Idec MA Inc. |
Use of dr6 and p75 antagonists to promote survival of cells of the nervous system
|
|
TW201034684A
(en)
*
|
2009-02-18 |
2010-10-01 |
Genentech Inc |
Method for inhibiting neurodegeneration
|
|
US9458427B2
(en)
*
|
2009-08-07 |
2016-10-04 |
Case Western Reserve University |
IFNγR2 compositions and methods of inhibiting neuronal cell death
|
|
WO2011060262A1
(en)
|
2009-11-12 |
2011-05-19 |
Pharmatrophix, Inc. |
Crystalline forms of neurotrophin mimetic compounds and their salts
|
|
BR112012009997A2
(pt)
*
|
2009-11-12 |
2019-09-24 |
Genentech Inc |
''método para aumentar a densidade de espinhas dentriticas nos neurônios de um paciente com um distúrbios cognitivo ou psiquiatrico,método de manutenção da cognição em um sujeito durante o processo de envelhecimento,uso de um antagonista de dr6 na preparação de um medicamento para uso em um paciente com um disturbio cognitivo uo psiquíatrico e uso de um antagonista de p75 na preparação de um medicamento para uso em um paciente com um distúrbio cognitivo ou psiquiátrico''
|
|
US10273219B2
(en)
|
2009-11-12 |
2019-04-30 |
Pharmatrophix, Inc. |
Crystalline forms of neurotrophin mimetic compounds and their salts
|
|
EP2542571B1
(en)
*
|
2010-03-03 |
2016-05-25 |
The University of British Columbia |
Oligomer-specific amyloid beta epitope and antibodies
|
|
AU2013205000B2
(en)
*
|
2010-03-03 |
2015-05-28 |
The University Of British Columbia |
Oligomer-specific amyloid beta epitope and antibodies
|
|
ES2628596T3
(es)
|
2010-11-29 |
2017-08-03 |
Akershus Universitetssykehus |
Procedimientos y composiciones para monitorizar la actividad fagocítica
|
|
EP2764120B1
(en)
*
|
2011-10-05 |
2020-06-10 |
Blanchette Rockefeller Neurosciences, Institute |
Stimulus-elicited genomic profile markers of a neurodegenerative condition
|
|
US9534016B2
(en)
*
|
2011-11-28 |
2017-01-03 |
Buck Institute For Research On Aging |
Netrin loop peptide mimetics and uses thereof
|
|
GB2516045A
(en)
*
|
2013-07-09 |
2015-01-14 |
Neuro Bio Ltd |
Neurodegenerative disorders
|
|
ES2699410T3
(es)
*
|
2014-05-28 |
2019-02-11 |
Univ Dresden Tech |
Ensayo basado en células y métodos de cribado de moduladores de la señalización de p75NTR
|
|
CA3051019A1
(en)
*
|
2017-03-06 |
2018-09-13 |
Jun Liu |
Inhibiting or alleviating agent for as-induced damage
|
|
CN111201030B
(zh)
|
2017-07-25 |
2024-11-01 |
真和制药有限公司 |
通过阻断tim-3和其配体的相互作用治疗癌症
|
|
JP6359160B2
(ja)
*
|
2017-07-25 |
2018-07-18 |
株式会社Ｍｃｂｉ |
認知機能障害疾患のバイオマーカーおよび該バイオマーカーを用いる認知機能障害疾患の検出方法
|
|
KR20210124308A
(ko)
|
2019-01-30 |
2021-10-14 |
트루바인딩 아이엔씨. |
항-gal3 항체 및 이의 용도
|
|
MX2022014786A
(es)
|
2020-05-26 |
2023-01-16 |
Truebinding Inc |
Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3.
|
|
CN119661638B
(zh)
*
|
2024-11-22 |
2025-07-18 |
象山县第一人民医院医疗健康集团(宁波市第四医院、宁波市第四医院医院管理研究所) |
一种修复神经损伤的多肽、制备方法及其应用
|